A study to assess the safety and tolerability of SB-681323 administered via the intravenous route
Phase of Trial: Phase I
Latest Information Update: 01 Jun 2012
At a glance
- Drugs Dilmapimod (Primary)
- Indications Atherosclerosis; Chronic obstructive pulmonary disease; Neuropathic pain; Rheumatoid arthritis
- Focus Adverse reactions
- 21 Mar 2007 New trial record.